Long-acting anticoagulant rodenticide poisoning: An evidence-based consensus guideline for out-of-hospital management

Clinical Toxicology

Volumn 45, Issue 1, 2007, Pages 1-22

  Caravati, E Martin ^a   Erdman, Andrew R ^a   Scharman, Elizabeth J ^a   Woolf, Alan D ^a   Chyka, Peter A ^a   Cobaugh, Daniel J ^a   Wax, Paul M ^a   Manoguerra, Anthony S ^a   Christianson, Gwenn ^a   Nelson, Lewis S ^a   Olson, Kent R ^a   Booze, Lisa L ^a   Troutman, William G ^a  

^a American Association of Poison Control Centers   (United States)

Author keywords

Poison control centers standards; Practice guidelines; Rodenticides poisoning

Indexed keywords

ACTIVATED CARBON; BENZODIAZEPINE; BRODIFACOUM; BROMADIOLONE; CANNABIS; CARBAMAZEPINE; CHLOROPHACINONE; CLONAZEPAM; CLORAZEPATE; COCAINE; DICOUMAROL; DIFENACOUM; DIPHENADIONE; FLUOXETINE; IPECAC; LEVOTHYROXINE; METHYLPHENIDATE; PHENOBARBITAL; PHYTOMENADIONE; RODENTICIDE; SOAP; TESTOSTERONE; VITAMIN K GROUP; WATER; ZOLPIDEM;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CAPILLARY RESISTANCE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEATH; DEPRESSION; DISEASE CLASSIFICATION; DRUG ABUSE; DRUG INTOXICATION; DRUG MISUSE; DRUG OVERDOSE; EMBRYOPATHY; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; EVALUATION; HEALTH CARE PERSONNEL; HEALTH PRACTITIONER; HUMAN; HYPOTHYROIDISM; MEDICAL INFORMATION SYSTEM; NONHUMAN; OUTPATIENT CARE; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; POISON CENTER; PREGNANT WOMAN; REVIEW; SCIENTIFIC LITERATURE; SEIZURE; SIDE EFFECT; SKIN DECONTAMINATION; SPONTANEOUS ABORTION; STILLBIRTH; STOMACH LAVAGE; SUBARACHNOID HEMORRHAGE; SYMPTOM; VOMITING;

ANTICOAGULANTS; EMERGENCY MEDICAL SERVICES; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; HUMANS; OUTPATIENTS; POISON CONTROL CENTERS; POISONING; RODENTICIDES; TRIAGE; UNITED STATES;

CEPHAELIS IPECACUANHA;

EID: 33847049943     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650600795487     Document Type: Review

References (71)

1. Toxic Exposure Surveillance System (TESS). Washington (DC): American Association of Poison Control Centers, 2004. Database accessed June 2005.
2. Chong LL, Chau WK, Ho CH. A case of "superwarfarin" poisoning. Scand J Haematol 1986; 36:314-315.
3. Chua JD, Friedenberg WR. Superwarfarin poisoning. Arch Intern Med 1998; 158:1929-1932.
4. Jones EC, Growe GH, Naiman SC. Prolonged anticoagulation in rat poisoning. JAMA 1984; 252:3005-3007.
5. Park BK, Choonara IA, Haynes BP, Breckenridge AM, Malia RG, Preston FE. Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. Br J Clin Pharmacol 1986; 21:289-293.
6. Svendsen SW, Kolstad HA, Steesby E. Bleeding problems associated with occupational exposure to anticoagulant rodenticides. Int Arch Occup Environ Health 2002; 75:515-517.
7. Babcock J, Hartman K, Pedersen A, Murphy M, Alving B. Rodenticide-induced coagulopathy in a young child. A case of Munchausen syndrome by proxy. Am J Pediatr Hematol Oncol 1993; 15:126-130.
8. Spiller HA, Gallenstein GL, Murphy MJ. Dermal absorption of a liquid diphacinone rodenticide causing coagulaopathy. Vet Hum Toxicol 2003; 45:313-314.
9. La Rosa FG, Clarke SH, Lefkowitz JB. Brodifacoum intoxication with marijuana smoking. Arch Pathol Lab Med 1997; 121:67-69.
10. Waien SA, Hayes D, Jr., Leonardo JM. Severe coagulopathy as a consequence of smoking crack cocaine laced with rodenticide. N Engl J Med 2001; 345:700-701.
11. Bachmann KA, Sullivan TJ. Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin-sensitive rats. Pharmacology 1983; 27:281-288.
12. Leck JB, Park BK. A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K1 metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats. Biochem Pharmacol 1981; 30:123-128.
13. Park BK, Leck JB. A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit. Biochem Pharmacol 1982; 31:3635-3639.
14. Hollinger BR, Pastoor TP. Case management and plasma half-life in a case of brodifacoum poisoning. Arch Intern Med 1993; 153:1925-1928.
15. Pavlu J, Harrington DJ, Voong K, Savidge GF, Jan-Mohamed R, Kaczmarski R. Superwarfarin poisoning. Lancet 2005; 365: 628.
16. Weitzel JN, Sadowski JA, Furie BC, Moroose R, Kim H, Mount ME, Murphy MJ, Furie B. Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases. Blood 1990; 76:2555-2559.
17. Bruno GR, Howland MA, McMeeking A, Hoffman RS. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med 2000; 36:262-267.
18. Lipton RA, Klass EM. Human ingestion of a "superwarfarin" rodenticide resulting in a prolonged anticoagulant effect. JAMA 1984; 252:3004-3005.
19. Burucoa C, Mura P, Robert R, Boinot C, Bouquet S, Piriou A. Chlorophacinone intoxication. A biological and toxicological study. J Toxicol Clin Toxicol 1989; 27:79-89.
20. Lagrange F, Corniot AG, Titier K, Bedry R, Pehourcq F. Toxicological management of chlorophacinone poisoning. Acta Clin Belg Suppl 1999; 1:13-16.
21. McCarthy PT, Cox AD, Harrington DJ, Evely RS, Hampton E, al-Sabah AI, Massey E, Jackson H, Ferguson T. Covert poisoning with difenacoum: clinical and toxicological observations. Hum Exp Toxicol 1997; 16:166-170.
22. Ingels M, Lai C, Tai W, Manning BH, Rangan C, Williams SR, Manoguerra AS, Albertson T, Clark RF. A prospective study of acute, unintentional, pediatric superwarfarin ingestions managed without decontamination. Ann Emerg Med 2002; 40:73-78.
23. Seidelmann S, Kubic V, Burton E, Schmitz L. Combined superwarfarin and ethylene glycol ingestion. A unique case report with misleading clinical history. Am J Clin Pathol 1995; 104:663-666.
24. Smolinske SC, Scherger DL, Kearns PS, Wruk KM, Kulig KW, Rumack BH. Superwarfarin poisoning in children: a prospective study. Pediatrics 1989; 84:490-494.
25. Barnett VT, Bergmann F, Humphrey H, Chediak J. Diffuse alveolar hemorrhage secondary to superwarfarin ingestion. Chest 1992; 102:1301-1302.
26. Emre S, Kitabayashi K, Miller CM. Successful liver transplantation from a donor with brodifacoum intoxication. Liver Transpl Surg 1999; 5:509-511.
27. Kruse JA, Carlson RW. Fatal rodenticide poisoning with brodifacoum. Ann Emerg Med 1992; 21:331-336.
28. Zupancic-Salek S, Kovacevic-Metelko J, Radman I. Successful reversal of anticoagulant effect of superwarfarin poisoning with recombinant activated factor VII. Blood Coagul Fibrinolysis 2005; 16: 239-244.
29. Casner PR. Superwarfarin toxicity. Am J Ther 1998; 5:117-120.
30. Hoffman RS, Smilkstein MJ, Goldfrank LR. Evaluation of coagulation factor abnormalities in long-acting anticoagulant overdose. J Toxicol Clin Toxicol 1988; 26:233-248.
31. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281:1900-1905.
32. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139:493-498.
33. Burkhart KK. Anticoagulant rodenticides. In: Ford MD, Delaney KA. Ling J, Erickson T. Clinical toxicology. Philadelphia: WB Saunders, 2001; 848-853.
34. Metts BC Jr, Stewart NJ Jr. Rodenticides. In: Haddad LM, Shannon MW, Winchester JF, eds. Clinical management of poisoning and drug overdose. 3rd ed. Philadelphia: WB Saunders, 1998; 864-875.
35. Su M, Hoffman RS. Anticoagulants. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. Goldfrank's toxicologic emergencies. 7th ed. New York: McGraw-Hill, 2002; 631-646.
36. Yip L. Anticoagulant rodenticides. In: Dart RC, ed. Medical toxicology. 3rd ed. Baltimore: Williams & Wilkins, 2004; 1497-1507.
37. Anticoagulants, long-acting management. In: Klasco RK, ed. Poisindex System. Greenwood Village (CO): Thomson Micromedex, edition expires September 2004.
38. Shepherd G, Klein-Schwartz W, Anderson BD. Acute, unintentional pediatric brodifacoum ingestions. Pediatr Emerg Care 2002; 18: 174-178.
39. Bennett DL, Caravati EM, Veltri JC. Long-acting anticoagulant ingestion: a prospective study [abstract]. Vet Hum Toxicol 1987; 29: 472-473.
40. Brands CS, Bartkus EA, Daya MR. Accidental superwarfarin ingestion: compliance with current Poisindex® guidelines [abstract]. J Toxicol Clin Toxicol 1995; 33:487.
41. Kanabar D, Volans G. Accidental superwarfarin poisoning in children - less treatment is better. Lancet 2002; 360:963.
42. Morrissey B, Burgess JL, Robertson WO. Washington's experience and recommendations. Re: anticoagulant rodenticides. Vet Hum Toxicol 1995; 37:362-363.
43. Mullins ME, Brands CL, Daya MR. Unintentional pediatric superwarfarin exposures: do we really need a prothrombin time? Pediatrics 2000; 105:402-404.
44. Polley K, Nichols MH, King WD. Superwarfarin ingestion: is observation alone the answer? [abstract] J Investig Med 1996; 44:A28.
45. Sullivan MP, Dean BS, Krenzelok EP. Long-acting anticoagulant rodenticides: an evaluation of 88 cases [abstract]. Vet Hum Toxicol 1989; 31:361.
46. Chuang J, Sadler MA, Witt DM. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-mL (pediatric) tubes. Chest 2004; 126:1262-1266.
47. Boyer LV, Griffith L, Fosdick CC III, Fernandez M. Prolonged coagulopathy after brodifacoum ingestion and the challenges in provision of continuing care [abstract]. J Toxicol Clin Toxicol 1998; 36:462.
48. Chen TW, Deng JF. A brodifacoum intoxication case of mouthful amount [abstract]. Vet Hum Toxicol 1986; 28:488.
49. Lewis-Younger C, Horowitz Z. Elimination of brodifacoum [abstract]. J Toxicol Clin Toxicol 2001; 39:474-475.
50. Morgan BW, Tomaszewski C, Rotker I. Spontaneous hemoperitoneum from brodifacoum overdose. Am J Emerg Med 1996; 14:656-659.
51. Ross GS, Zacharski LR, Robert D, Rabin DL. An acquired hemorrhagic disorder from long-acting rodenticide ingestion. Arch Intern Med 1992; 152:410-412.
52. Sheen SR, Spiller HA, Grossman D. Symptomatic brodifacoum ingestion requiring high-dose phytonadione therapy. Vet Hum Toxicol 1994; 36:216-217.
53. Zurawski JM, Kelly EA. Pregnancy outcome after maternal poisoning with brodifacoum, a long-acting warfarin-like rodenticide. Obstet Gynecol 1997; 90:672-674.
54. Haug B, Schjodt-Iversen L, Rygh J. Forgiftninger med langtidsvirkende antikoagulanter. Tidsskr Nor Laegeforen 1992; 112:1958-1960.
55. Chataigner D, Garnier R, Elmalem J, Efthymiou ML. Hypocoagulabilit& eacute; prolong& eacute;e secondaire & agrave; l'ingestion de raticides anticoagulants. Ann Med Interne (Paris) 1989; 139: 537-541.
56. Murdoch DA. Prolonged anticoagulation in chlorphacinone poisoning. Lancet 1983; 1:355-356.
57. Vogel JJ, de Moerloose P, Bouvier CA, Gaspoz J, Riant P. Anticoagulation prolong& eacute;e lors d'une intoxication & agrave; la chlorphacinone. Schweiz Med Wochenschr 1988; 118:1915-1917.
58. Barlow AM, Gay AL, Park BK. Difenacoum (Neosorexa) poisoning. Br Med J (Clin Res Ed) 1982; 285:541.
59. Hayes WJ. Pesticides studied in man. Baltimore: Williams & Wilkins, 1982; 512-513.
60. Field JB, Goldfarb MS, Ware AG, Griffith GC. Dipaxin: 2-diphenylacetyl-1,3-indandione; clinical evaluation of a new anticoagulant. Circulation 1955; 11:576-583.
61. Pascale LR, Olwin JH. Clinical experience with a new anticoagulant, dipaxin (2-diphenylacetyl-1,3-indandione). Circulation 1954; 9: 230-237.
62. Corke PJ. Superwarfarin (brodifacoum) poisoning. Anaesth Intensive Care 1997; 25:707-709.
63. 1 therapy. Pharmacotherapy 2003; 23:1186-1189.
64. Butcher GP, Shearer MJ, MacNicoll AD, Kelly MJ, Ind PW. Difenacoum poisoning as a cause of haematuria. Hum Exp Toxicol 1992; 11:553-554.
65. Terneu S, Verhelst D, Thys F, Ketelslegers E, Hantson P, Wittebole X. An unusual cause of abdominal pain. Acta Clin Belg 2003; 58:241-244.
66. Greeff MC, Mashile O, MacDougall LG. "Superwarfarin" (bromodialone) poisoning in two children resulting in prolonged anticoagulation. Lancet 1987; 2:1269.
67. Watts RG, Castleberry RP, Sadowski JA. Accidental poisoning with a superwarfarin compound (brodifacoum) in a child. Pediatrics 1990; 86:883-887.
68. Dahl B, Caravati M, Dunson W. Surreptitious brodifacoum poisoning [abstract]. J Toxicol Clin Toxicol 1998; 36:475-476.
69. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Sixth ed, Williams and Wilkins, Baltimore, 2002; 327-334.
70. Donovan JW, Ballard JO, Murphy MJ. Brodifacoum therapy with activated charcoal: effect on elimination kinetics [abstract]. Vet Hum Toxicol 1990; 32:350.
71. Environmental Protection Agency (US), Reregistration Eligibility Decision (RED): Rodenticide Cluster, July, EPA 738-R-98-007. www.epa.gov/REDs/2100red. pdf. 1998Document accessed June 6, 2005.